Atorvastatin Calcium
Product Images NDC 53808-0959

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53808-0959). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 10mg (10mg Apotex)

This is a description of a medication called Atorvastatin Calcium. The medication comes in 10mg tablets and is packaged in a bottle with a quantity of 30 tablets. The lot number of the medication is KN3789, and the expiration date is 08-05-2014. The medication was packaged by DO Central Pharmacy in Tallahassee, FL. The UPC code for the medication is 380505257898.*

FDA Label Image

Label Image For 40mg (40mg Apotex)

ATORVASTATIN CALCIUM 40MG TABS is a prescription medication manufactured by Apotex Corp and packaged by DOH Central Pharmacy. The package contains 30 tablets with a DOH LOT# 0841201382, and an expiry date of March 11, 2014. The medication is likely used for the treatment of high cholesterol. The last line of the text contains non-English characters and is not usable.*

FDA Label Image

Figure-01 (Figure 01)

FDA Label Image

Figure-02 (Figure 02)

This appears to be a partial output of a statistical analysis report. It includes a table showing the cumulative hazard percentage at 10 and 15, as well as data related to the drug Atorvastatin, which has an HR (hazard ratio) of 0.53 at a confidence interval of 0.45-0.83. The chart appears to show follow-up data for a period of four years, but not enough information is given to provide a detailed description or interpretation of the output.*

FDA Label Image

Figure-03 (Figure 03)

The text shows the percentage of subjects who experienced E vert after taking Horvastatin 10 mg and Sorvastatin 80 mg. It also mentions the HR (Hazard Ratio) and P-value for the two drugs. Additionally, the text displays a graph that depicts the time taken to reach the first major cardiovascular endpoint for four different scenarios.*

FDA Label Image

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.